Literature DB >> 25186106

Uricaemia and left ventricular mass in hypertensive patients.

Cristiana Catena1, GianLuca Colussi, Frine Capobianco, Gabriele Brosolo, Leonardo A Sechi.   

Abstract

BACKGROUND: Both hyperuricaemia and left ventricular (LV) hypertrophy are associated with the metabolic syndrome and increased cardiovascular risk. The relationship between uric acid levels and left ventricular mass in hypertension, however, is unclear. In this study, we have investigated this relationship in hypertensive patients without the metabolic syndrome.
MATERIALS AND METHODS: In a cross-sectional study, 367 nondiabetic, essential hypertensive patients (age 52 ± 14; 194 males and 173 females) free of clinically relevant cardiovascular complications and without the metabolic syndrome were consecutively recruited at a university hypertension clinic. In these patients, we measured plasma levels of uric acid, lipids, glucose and insulin at fast and after an oral glucose load (OGTT), renal function and performed both conventional and tissue Doppler echocardiography.
RESULTS: Hypertensive patients with LV hypertrophy had higher uric acid levels and greater prevalence of hyperuricemia than patients with normal left ventricular mass. Uric acid levels were directly related with fasting and post-OGTT plasma insulin and with the HOMA index and inversely with 24-h creatinine clearance. Uric acid was also significantly and directly related with the left ventricular mass and multivariate regression analysis showed that this relationship was independent from components of the metabolic syndrome and renal function in women, but not in men.
CONCLUSIONS: Elevated uric acid levels are independently related to the left ventricular mass in hypertensive women without the metabolic syndrome. In these patients with a low cardiovascular risk profile, uric acid might contribute to the development of subclinical cardiac damage.
© 2014 Stichting European Society for Clinical Investigation Journal Foundation.

Entities:  

Keywords:  Hypertension; left ventricular hypertrophy; metabolic syndrome; tissue Doppler echocardiography; uric acid

Mesh:

Substances:

Year:  2014        PMID: 25186106     DOI: 10.1111/eci.12331

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  6 in total

1.  Cardiovascular Risk in Patients With Takayasu Arteritis Directly Correlates With Diastolic Dysfunction and Inflammatory Cell Infiltration in the Vessel Wall: A Clinical, ex vivo and in vitro Analysis.

Authors:  Sebastiano Cicco; Vanessa Desantis; Antonio Vacca; Gerardo Cazzato; Antonio G Solimando; Anna Cirulli; Silvia Noviello; Cecilia Susca; Marcella Prete; Gabriele Brosolo; Cristiana Catena; Aurelia Lamanuzzi; Ilaria Saltarella; Maria Antonia Frassanito; Antonella Cimmino; Giuseppe Ingravallo; Leonardo Resta; Roberto Ria; Monica Montagnani
Journal:  Front Med (Lausanne)       Date:  2022-05-16

2.  Increased Serum Uric Acid Level Is a Risk Factor for Left Ventricular Hypertrophy but Not Independent of eGFR in Patients with Type 2 Diabetic Kidney Disease.

Authors:  Chuchu Zeng; Dongsheng Cheng; Xiaohua Sheng; Guihua Jian; Ying Fan; Yuqiang Chen; Junhui Li; Hongda Bao; Niansong Wang
Journal:  J Diabetes Res       Date:  2017-06-20       Impact factor: 4.011

3.  Association between insulin resistance and left ventricular hypertrophy in asymptomatic, Black, sub-Saharan African, hypertensive patients: a case-control study.

Authors:  Bernard Kianu Phanzu; Aliocha Nkodila Natuhoyila; Eleuthère Kintoki Vita; Jean-René M'Buyamba Kabangu; Benjamin Longo-Mbenza
Journal:  BMC Cardiovasc Disord       Date:  2021-01-02       Impact factor: 2.298

4.  Serum Uric Acid and Left Ventricular Mass in Essential Hypertension.

Authors:  Valeria Visco; Antonietta Valeria Pascale; Nicola Virtuoso; Felice Mongiello; Federico Cinque; Renato Gioia; Rosa Finelli; Pietro Mazzeo; Maria Virginia Manzi; Carmine Morisco; Francesco Rozza; Raffaele Izzo; Federica Cerasuolo; Michele Ciccarelli; Guido Iaccarino
Journal:  Front Cardiovasc Med       Date:  2020-11-26

5.  Effect of Long-Term Allopurinol Therapy on Left Ventricular Mass Index in Patients with Ischemic Heart Disease; A Cross-Sectional Study.

Authors:  Manal M Alem; Sarah R Aldosari; Alhassna A Alkahmous; Adam S Obad; Nagy M Fagir; Bandar S Al-Ghamdi
Journal:  Vasc Health Risk Manag       Date:  2019-12-06

6.  Serum uric acid and left ventricular hypertrophy in hypertensive patients in Ado-Ekiti.

Authors:  Oladapo Adedamola Adewuya; Ebenezer Adekunle Ajayi; Rasaaq Ayodele Adebayo; Opeyemi Ezekiel Ojo; Olatunji Bukola Olaoye
Journal:  Pan Afr Med J       Date:  2020-07-16
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.